The debut of troglitazone, a potent glucose-lowering agent, marked a important chapter in the management of type 2 diabetes. However, its withdrawal from the market due to severe hepatotoxicity spurred considerable https://lawsoneoyk715101.blog-gold.com/57454256/troglitazone-and-related-glitazones-a-relative-overview